Literature DB >> 6094998

Expression of HTLV-specific polypeptides in various human T-cell lines.

Y Koyanagi, Y Hinuma, J Schneider, T Chosa, G Hunsmann, N Kobayashi, M Hatanaka, N Yamamoto.   

Abstract

The adult T-cell leukemia (ATL)-associated antigen complex (ATLA) was first discovered with indirect immunofluorescence by Hinuma et al. (1981). Biochemical analysis with MT-2 cells revealed that ATLA consisted mainly of human T-cell leukemia virus (HTLV) structural polypeptides and their precursors (Yamamoto and Hinuma 1982a; Schneider et al. 1984). In this study, we have investigated the molecular nature of the ATLA antigen complex in various HTLV-positive human cell lines established by different methods including independently established HTLV-infected HUT 102 cells. We found that HTLVs infecting these cell lines have similar core polypeptides, p24 and p19, as well as an envelope glycopolypeptide, gp46, in all these cells. The intracellular gp61 and p53 appear to be precursors of the viral envelope and core polypeptides, respectively. Interestingly, MT-2 and MT-2 related T-cell lines contain two different species of envelope proteins, gp68 and gp61, whereas cell lines not related to MT-2 express only gp61.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6094998     DOI: 10.1007/bf02123761

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  31 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Monoclonal antibody reactive with both p28 and p19 of adult T-cell leukemia virus-specific polypeptides.

Authors:  Y Tanaka; Y Koyanagi; T Chosa; N Yamamoto; Y Hinuma
Journal:  Gan       Date:  1983-06

3.  HTLV type I (U. S. isolate) and ATLV (Japanese isolate) are the same species of human retrovirus.

Authors:  T Watanabe; M Seiki; M Yoshida
Journal:  Virology       Date:  1984-02       Impact factor: 3.616

4.  Adult T-cell leukemia (ATL) virus-specific antibodies in ATL patients and healthy virus carriers.

Authors:  N Yamamoto; J Schneider; Y Koyanagi; Y Hinuma; G Hunsmann
Journal:  Int J Cancer       Date:  1983-09-15       Impact factor: 7.396

5.  A novel T-cell line derived from adult T-cell leukemia.

Authors:  I Miyoshi; I Kubonishi; M Sumida; S Hiraki; T Tsubota; I Kimura; K Miyamoto; J Sato
Journal:  Gan       Date:  1980-02

6.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

7.  Identification of envelope glycoprotein encoded by env gene of human T-cell leukemia virus.

Authors:  S Hattori; K Imagawa; F Shimizu; E Hashimura; M Seiki; M Yoshida
Journal:  Gan       Date:  1983-12

8.  Adult T-cell leukemia-associated antigen (ATLA): detection of a glycoprotein in cell- and virus-free supernatant.

Authors:  N Yamamoto; J Schneider; Y Hinuma; G Hunsmann
Journal:  Z Naturforsch C Biosci       Date:  1982 Jul-Aug

9.  Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells.

Authors:  M Kannagi; K Sugamura; H Sato; K Okochi; H Uchino; Y Hinuma
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Translation of HTLV (human T-cell leukemia virus) RNA in a nuclease-treated rabbit reticulocyte system.

Authors:  N Kobayashi; N Yamamoto; Y Koyanagi; J Schneider; G Hunsmann; M Hatanaka
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  11 in total

1.  Monoclonal antibodies and chemiluminescence immunoassay for detection of the surface protein of human T-cell lymphotropic virus.

Authors:  L D Papsidero; R P Dittmer; L Vaickus; B J Poiesz
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

2.  HTLV-I antibody studies in villagers in East Sepik Province, Papua New Guinea.

Authors:  R C Sanders; A Levin; G Anian; I Webber; H Lee; P Swanson; A Diwan; R Desowitz; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

4.  Human T-cell leukemia virus type-I (HTLV-I) tax is not the only one factor to enhance human immunodeficiency virus type-I (HIV-1) infection in culture-supernatants.

Authors:  A Tempaku; Y Maeda; W Song; S Harada
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

5.  In vivo genomic footprinting of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeat enhancer sequences in HTLV-1-infected human T-cell lines with different levels of Tax I activity.

Authors:  S Datta; N H Kothari; H Fan
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.

Authors:  Soratree Charoenthongtrakul; Qinjie Zhou; Noula Shembade; Nicole S Harhaj; Edward W Harhaj
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  Evaluation of the effect of pyrimethamine, an anti-malarial drug, on HIV-1 replication.

Authors:  Raphael M Oguariri; Joseph W Adelsberger; Michael W Baseler; Tomozumi Imamichi
Journal:  Virus Res       Date:  2010-08-26       Impact factor: 3.303

8.  Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.

Authors:  M Cecilia M Parrula; Soledad A Fernandez; Kristina Landes; Devra Huey; Michael Lairmore; Stefan Niewiesk
Journal:  Virus Res       Date:  2014-06-06       Impact factor: 3.303

9.  Comparative studies of commercially available particle agglutination assay and enzyme-linked immunosorbent assay for screening of human T-cell leukemia virus type I antibodies in blood donors.

Authors:  S Kobayashi; T Yoshida; Y Hiroshige; T Matsui; N Yamamoto
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

10.  Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation.

Authors:  Christine Ludwig; Andreas Leiherer; Ralf Wagner
Journal:  J Virol       Date:  2008-03-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.